This Sandbox is Reserved from January 10, 2010, through April 10, 2011 for use in BCMB 307-Proteins course taught by Andrea Gorrell at the University of Northern British Columbia, Prince George, BC, Canada.
To get started:
  • Click the edit this page tab at the top. Save the page after each step, then edit it again.
  • Click the 3D button (when editing, above the wikitext box) to insert Jmol.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

PDB ID 1bzy

Drag the structure with the mouse to rotate
1bzy, resolution 2.00Å ()
Ligands: , ,
Activity: Hypoxanthine phosphoribosyltransferase, with EC number 2.4.2.8
Resources: FirstGlance, OCA, RCSB, PDBsum
Coordinates: save as pdb, mmCIF, xml



Hypoxanthine-guanine phosphoribosyltransferaseHypoxanthine-guanine phosphoribosyltransferase

IntroductionIntroduction

Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) is a key enzyme in purine salvage pathways. This enzyme salvages guanine directly and adenine indirectly from catabolism. It catalyzes the reversible transfer of the phosphoribosyl group from a-D-5-phosphoribosyl 1-pyrophosphate (PRPP) to hypoxanthine or guanine forming either IMP or GMP, respectively. This reaction is dependent on a divalent magnesium cation. HGPRT is deficient in Lesch-Nyhan syndrome, a severe neurological disorder characterized by high levels of blood uric acid and uncontrollable self mutilation. A partial deficiency of the enzyme leads to gouty arthritis. [1]

StructureStructure

HGPRT belongs to a group of enzymes known as phosphoribosyltransferases (PRTases), which are involved in purine, pyrimidine and amino acid synthesis. HGPRT is a tetramer, which is required for enzyme function, since three of the four subunits contribute residues to each active site. [2] The structures of PRTases fall into two groups, type 1 and type 2; HGPRT falls into the type 1 category. A common alpha/beta-fold called the PRPP motif and a flexible are structural characteristics of type 1 PRTases. Type 1 PRTases also have a core region containing at least five or more parallel beta strands surrounded by three or four helices. Type 2 PRTases do not have a PRPP motif and are composed of a alpha/beta N terminal domain and a alpha/beta barrel-like C terminal doimain. The characteristic loop of type 1 PRTases closes after substrate binding and is thought to sequester the active site from solvent during catalysis. In the crystal structure of the human HGPRT-GMP complex, the loop is open and the active site is exposed to the solvent. The PRTase from the parasite, Toxoplasma gondii, has a mobile loop that partially covers the active site, whereas the flexible loop in Trypanosoma cruzii does not sequester the second active site from solvent. [1]

FunctionFunction

Hypoxanthine-guanine phosphoribosyltransferase is present in many human tissues with the most specific activities occurring in the brain, placenta, gonads, erythrocytes, fibroblasts, and leukocytes. It's role is the conservation of purine bases that might otherwise be degraded to uric acid.[3]

MechanismMechanism

hypoxanthine-guanine phosphoribosyltransferase

Drag the structure with the mouse to rotate

A base, either hypoxanthine or guanine, reacts with PRPP to form nucleoside monophosphate and pyrophosphate. The reaction, catalyzed by HGPRT, is reversible with rapid phosphoribosyl transfer in both the forward and reverse directions. In the forward direction PRPP binding occurs before GMP or IMP binding. Pyrophosphate then rapidly dissociates after the transition state followed by the release of the nucleoside monophosphate. In the reverse direction GMP or IMP binding precedes PRPP binding. The base then rapidly dissociates, whereas PRPP dissociates slowly. The corresponding to Glu 133 and Asp 134 stabilize the oxocarbenium ion at the transition state. [4]

Additional ResourcesAdditional Resources

For additional information on PRTases, see: Sandbox Reserved 342


ReferencesReferences

  1. 1.0 1.1 Shi W, Li CM, Tyler PC, Furneaux RH, Grubmeyer C, Schramm VL, Almo SC. The 2.0 A structure of human hypoxanthine-guanine phosphoribosyltransferase in complex with a transition-state analog inhibitor. Nat Struct Biol. 1999 Jun;6(6):588-93. PMID:10360366 doi:http://dx.doi.org/10.1038/9376
  2. Vos S, Parry RJ, Burns MR, de Jersey J, Martin JL. Structures of free and complexed forms of Escherichia coli xanthine-guanine phosphoribosyltransferase. J Mol Biol. 1998 Oct 2;282(4):875-89. PMID:9743633 doi:10.1006/jmbi.1998.2051
  3. Fox IH, Dwosh IL, Marchant PJ, Lacroix S, Moore MR, Omura S, Wyhofsky V. Hypoxanthine-guanine phoshoribosyltransferase: characterization of a mutant in a patient with gout. Journal of Clinical Investigation. 1975 Nov;56(5):1239-49. PMCID:PMC301987 doi:10.1172/JCI108200
  4. Xu Y, Eads J, Sacchettini JC, Grubmeyer C. Kinetic mechanism of human hypoxanthine-guanine phosphoribosyltransferase: rapid phosphoribosyl transfer chemistry. Biochemistry. 1997 Mar 25;36(12):3700-12. PMID:9132023 doi:10.1021/bi9616007

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA, Farrah Glanfield